These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4682924)

  • 1. Effect of an inhibitor of glucuronide formation on elimination kinetics of diphenylhydantoin in rats.
    Levy G; Ashley JJ
    J Pharm Sci; 1973 Jan; 62(1):161-2. PubMed ID: 4682924
    [No Abstract]   [Full Text] [Related]  

  • 2. Diphenylhydantoin.
    Glazko AJ
    Pharmacology; 1972; 8(1):163-77. PubMed ID: 4630160
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of diphenylhydantoin elimination by its major metabolite.
    Ashley JJ; Levy G
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):297-306. PubMed ID: 5074529
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of temperature on the kinetics of propranolol, theophylline, phenytoin and digoxin in rats (author's transl)].
    Albin H; Vincon G; Ploux D; Dangoumau J
    J Pharmacol; 1981; 12(3):229-38. PubMed ID: 7289622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid and the half-life of diphenylhydantoin in man.
    Andreasen PB; Hansen JM; Skovsted L; Siersbaek-Nielsen K
    Acta Neurol Scand; 1971; 47(1):117-9. PubMed ID: 5576217
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism in vitro of 5,5-diphenylhydantoin.
    Gabler WL; Hubbard GL
    Biochem Pharmacol; 1972 Nov; 21(22):3071-3. PubMed ID: 4405453
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomes.
    Kutt H; Haynes J; Verebely K; McDowell F
    Neurology; 1969 Jun; 19(6):611-6. PubMed ID: 5814306
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of phenytoin clearance by valproic acid in normal subjects.
    Frigo GM; Lecchini S; Gatti G; Perucca E; Crema A
    Br J Clin Pharmacol; 1979 Dec; 8(6):553-6. PubMed ID: 391257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diphenylhydantoin elimination kinetics in overdosed children.
    Garrettson LK; Jusko WJ
    Clin Pharmacol Ther; 1975 Apr; 17(4):481-91. PubMed ID: 1122689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study of a patient with diphenylhydantoin toxicity.
    Atkinson AJ; Shaw JM
    Clin Pharmacol Ther; 1973; 14(4):521-8. PubMed ID: 4198768
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenytoin prodrugs V: In vivo evaluation of some water-soluble phenytoin prodrugs in dogs.
    Varia SA; Stella VJ
    J Pharm Sci; 1984 Aug; 73(8):1080-7. PubMed ID: 6548519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of diphenylhydantoin elimination in rats.
    Ashley JJ; Levy G
    J Pharmacokinet Biopharm; 1973 Apr; 1(2):99-102. PubMed ID: 4764428
    [No Abstract]   [Full Text] [Related]  

  • 13. Study of dose-dependent metabolism of 5,5-diphenyl-hydantoin in the rat using new methodology for isolation and quantitation of metabolites in vivo and in vitro.
    Gerber N; Weller WL; Lynn R; Rangno RE; Sweetman BJ; Bush MT
    J Pharmacol Exp Ther; 1971 Sep; 178(3):567-79. PubMed ID: 5571905
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenytoin kinetics in children.
    Dodson WE
    Clin Pharmacol Ther; 1980 May; 27(5):704-7. PubMed ID: 7371368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and metabolism of diphenylhydantoin in the isolated perfused rat liver.
    Inaba T; Umeda T; Endrenyi L; Mahon WA; Kalow W
    Biochem Pharmacol; 1978; 27(8):1151-8. PubMed ID: 697916
    [No Abstract]   [Full Text] [Related]  

  • 16. [The significance of cumulation and elimination for the determination of Phenytoin (diphenylhydantoin)].
    Remmer H; Hirschmann J; Greiner I
    Dtsch Med Wochenschr; 1969 Jun; 94(24):1265-72. PubMed ID: 5771073
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients.
    Morselli PL; Rizzo M; Garattini S
    Ann N Y Acad Sci; 1971 Jul; 179():88-107. PubMed ID: 5285399
    [No Abstract]   [Full Text] [Related]  

  • 18. Further observations on the interactions between phenobarbital and diphenylhydantoin during chronic treatment in the rat.
    Rizzo M; Morselli PL; Garattini S
    Biochem Pharmacol; 1972 Feb; 21(4):449-54. PubMed ID: 5014504
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of sulphonylureas (tolazamide, tolbutamide and chlorpropamide) on the metabolism of diphenylhydantoin in the rat.
    Wesseling H; Thurkow I; Mulder G
    Biochem Pharmacol; 1973 Dec; 22(23):3033-40. PubMed ID: 4761563
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and distribution of diphenylhydantoin in kittens.
    Tobin T; Dirdjosudjono S; Baskin SI
    Am J Vet Res; 1973 Jul; 34(7):951-4. PubMed ID: 4720683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.